Literature DB >> 18371536

Differential expression of proteins from cultured endothelial cells exposed to uremic versus normal serum.

Carla Carbó1, Gemma Arderiu, Ginés Escolar, Berta Fusté, Aleix Cases, Montserrat Carrascal, Joaquín Abián, Maribel Díaz-Ricart.   

Abstract

BACKGROUND: Deficient hemostasis and accelerated atherosclerosis coexist in patients with chronic kidney disease. Endothelial dysfunction may be involved in the high incidence of atherothrombotic events in these patients. We established an in vitro model of endothelial dysfunction by exposing endothelial cells to uremic media and applied a proteomic approach to characterize endothelial cell dysfunction in uremia. STUDY
DESIGN: Cross-sectional study. SETTING AND PARTICIPANTS: Serum samples from 8 patients with chronic kidney disease on hemodialysis treatment were collected. PREDICTOR: Exposure of cultured endothelial cells to normal and uremic serum. OUTCOME AND MEASUREMENTS: Proteins from lysed cells were characterized by isoelectric point and molecular weight by using 2-dimensional gel electrophoresis. Spots were visualized by means of silver staining and identified by using mass spectrometry.
RESULTS: Identification of the most prominent proteins showed molecules related to inflammation (high mobility group box 1, aldose reductase, and proteasome components) and oxidative stress (superoxide dismutase and glutathione peroxidase), both associated with chronic kidney disease. These changes may be caused by activation of the nuclear factor-kappaB transcription factor. Changes in expression of cytoskeletal proteins (destrin and vimentin) also were detected. LIMITATIONS: In vitro study.
CONCLUSION: Proteomic techniques proved to be a powerful tool to investigate endothelial dysfunction in uremia. A more exhaustive analysis will provide answers and potential therapeutic targets in the near future.

Entities:  

Mesh:

Year:  2008        PMID: 18371536     DOI: 10.1053/j.ajkd.2007.11.029

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  10 in total

1.  The role of actin depolymerizing factor in advanced glycation endproducts-induced impairment in mouse brain microvascular endothelial cells.

Authors:  Xinfeng Liu; Rongju Zhang; Hai Di; Dengfa Zhao; Jun Wang
Journal:  Mol Cell Biochem       Date:  2017-04-04       Impact factor: 3.396

2.  Overexpression of actin-depolymerizing factor blocks oxidized low-density lipoprotein-induced mouse brain microvascular endothelial cell barrier dysfunction.

Authors:  Jun Wang; Lu Sun; Yan-Fang Si; Bao-Min Li
Journal:  Mol Cell Biochem       Date:  2012-08-29       Impact factor: 3.396

3.  LDL-lipids from patients with hypercholesterolaemia and Alzheimer's disease are inflammatory to microvascular endothelial cells: mitigation by statin intervention.

Authors:  H K Irundika Dias; Caroline L R Brown; M Cristina Polidori; Gregory Y H Lip; Helen R Griffiths
Journal:  Clin Sci (Lond)       Date:  2015-09-23       Impact factor: 6.124

4.  NFκB in the development of endothelial activation and damage in uremia: an in vitro approach.

Authors:  Carolina Caballo; Marta Palomo; Aleix Cases; Ana M Galán; Patricia Molina; Manel Vera; Xavier Bosch; Gines Escolar; Maribel Diaz-Ricart
Journal:  PLoS One       Date:  2012-08-22       Impact factor: 3.240

Review 5.  Endothelial Damage, Inflammation and Immunity in Chronic Kidney Disease.

Authors:  Maribel Diaz-Ricart; Sergi Torramade-Moix; Georgina Pascual; Marta Palomo; Ana Belen Moreno-Castaño; Julia Martinez-Sanchez; Manel Vera; Aleix Cases; Gines Escolar
Journal:  Toxins (Basel)       Date:  2020-06-01       Impact factor: 4.546

6.  Most exposed: the endothelium in chronic kidney disease.

Authors:  Marc Vila Cuenca; Peter L Hordijk; Marc G Vervloet
Journal:  Nephrol Dial Transplant       Date:  2020-09-01       Impact factor: 5.992

7.  Apixaban Downregulates Endothelial Inflammatory and Prothrombotic Phenotype in an In Vitro Model of Endothelial Dysfunction in Uremia.

Authors:  Sergi Torramade-Moix; Marta Palomo; Manel Vera; Didac Jerez; Ana Belen Moreno-Castaño; M Urooj Zafar; Jordi Rovira; Fritz Diekmann; Joan Carles Garcia-Pagan; Gines Escolar; Aleix Cases; Maribel Diaz-Ricart
Journal:  Cardiovasc Drugs Ther       Date:  2021-06       Impact factor: 3.727

Review 8.  The molecular mechanisms of hemodialysis vascular access failure.

Authors:  Akshaar Brahmbhatt; Andrea Remuzzi; Marco Franzoni; Sanjay Misra
Journal:  Kidney Int       Date:  2016-02       Impact factor: 10.612

9.  Astragalus polysaccharide, a component of traditional Chinese medicine, inhibits muscle cell atrophy (cachexia) in an in vivo and in vitro rat model of chronic renal failure by activating the ubiquitin-proteasome pathway.

Authors:  Zhenbo Geng; Lianbo Wei; Chunhua Zhang; Xiaohua Yan
Journal:  Exp Ther Med       Date:  2017-05-22       Impact factor: 2.447

10.  Up-regulation of HDACs, a harbinger of uraemic endothelial dysfunction, is prevented by defibrotide.

Authors:  Marta Palomo; Manel Vera; Susana Martin; Sergi Torramadé-Moix; Julia Martinez-Sanchez; Ana Belen Moreno; Enric Carreras; Ginés Escolar; Aleix Cases; Maribel Díaz-Ricart
Journal:  J Cell Mol Med       Date:  2019-11-28       Impact factor: 5.310

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.